Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-22-000568
Filing Date
2022-09-20
Accepted
2022-09-20 16:57:24
Documents
1
Group Members
ARCH VENTURE FUND VIII OVERAGE, L.P.ARCH VENTURE PARTNERS VIII, L.P.ARCH VENTURE PARTNERS VIII, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VIII, L.P. -- CODIAK BIOSCIENCES, INC. -- SCHEDULE 13D archviii.htm SC 13D 267486
  Complete submission text file 0001072613-22-000568.txt   269352
Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 776-380-6600
ARCH Venture Fund VIII, L.P. (Filed by) CIK: 0001605598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Subject) CIK: 0001659352 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91823 | Film No.: 221254297
SIC: 2836 Biological Products, (No Diagnostic Substances)